Ingar Holme
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ingar Holme has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Serena Tonstad
Department of Preventive Cardiology , Oslo University Hospital Ullevål , Oslo , Norway
3 shared publications- Alan George Jardine
BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
1 shared publication Anders Hartmann
Oslo University Hospital, Rikshospitalet, Oslo, Norway
1 shared publicationBengt C. Fellström
University Hospital, Uppsala, Sweden
1 shared publicationHallvard Holdaas
Oslo University Hospital, Rikshospitalet, Oslo, Norway
1 shared publicationSigmund A. Anderssen
Seksjon for idrettsmedisinske fag Norges idrettshøgskole
1 shared publication
Latest Publications
- 1 March 2015
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 26 (2) , 123-126
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972–3
- 1 March 2015
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 26 (2) , 123-126
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972–3
- Open Access
- 21 January 2015
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 44 (3) , 434-439
Survival in elderly men in relation to midlife and current BMI
Background: the relationship between BMI and mortality is U-shaped in the elderly but may be modified by midlife BMI and change in weight. Objective: to elucidate mortality prediction by BMI trajectory in older men. Subjects: the Oslo cohort of men born in 1923–32 were screened for BMI and cardiovascular risk in 1972–73. Survivors were rescreened at ages of 68–77 years, and all-cause mortality was followed from 2000 to 2011. Methods: we calculated Cox regression proportional hazards for 11-year mortality rates in relation to BMI change among 5,240 men with no reported disease in 1972–73 and complete data. Models were adjusted for demographics, medications and disease. Men with BMI < 25 kg/m2 in midlife (1972–73) and in 2000 were the reference group. Results: men whose BMI changed from 2 in midlife to 25–29.9 kg/m2 in 2000 carried the lowest mortality risk (hazard ratio [HR] 0.84; 95% confidence interval [CI] 0.75–0.94). Men with BMI ≥ 30 kg/m2 in midlife were at highest risk (HR 1.79; 95% CI 1.12–2.88 if reclassified to 25–29.9 kg/m2 in 2000 and HR 1.39; 95% CI 1.05–1.85 if BMI remained ≥30 kg/m2 in 2000). Men with BMI 25–29.9 kg/m2 in midlife that reclassified to 2 in 2000 had increased risk. Findings were similar when percentage change in BMI was the outcome. Conclusion: survival in older men with normal weight at midlife was associated with BMI gain after midlife while midlife obesity increased risk regardless of subsequent change.
- 21 January 2015
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 44 (3) , 434-439
Open AccessSurvival in elderly men in relation to midlife and current BMI
Background: the relationship between BMI and mortality is U-shaped in the elderly but may be modified by midlife BMI and change in weight. Objective: to elucidate mortality prediction by BMI trajectory in older men. Subjects: the Oslo cohort of men born in 1923–32 were screened for BMI and cardiovascular risk in 1972–73. Survivors were rescreened at ages of 68–77 years, and all-cause mortality was followed from 2000 to 2011. Methods: we calculated Cox regression proportional hazards for 11-year mortality rates in relation to BMI change among 5,240 men with no reported disease in 1972–73 and complete data. Models were adjusted for demographics, medications and disease. Men with BMI < 25 kg/m2 in midlife (1972–73) and in 2000 were the reference group. Results: men whose BMI changed from 2 in midlife to 25–29.9 kg/m2 in 2000 carried the lowest mortality risk (hazard ratio [HR] 0.84; 95% confidence interval [CI] 0.75–0.94). Men with BMI ≥ 30 kg/m2 in midlife were at highest risk (HR 1.79; 95% CI 1.12–2.88 if reclassified to 25–29.9 kg/m2 in 2000 and HR 1.39; 95% CI 1.05–1.85 if BMI remained ≥30 kg/m2 in 2000). Men with BMI 25–29.9 kg/m2 in midlife that reclassified to 2 in 2000 had increased risk. Findings were similar when percentage change in BMI was the outcome. Conclusion: survival in older men with normal weight at midlife was associated with BMI gain after midlife while midlife obesity increased risk regardless of subsequent change.
- 9 January 2015
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 43 (2) , 117-122
Long-term survival in pre-specified groups at risk in the Oslo Study, 1972–1973
Aims: Using the Oslo Study of 1972–1973, we wished to compare the long-term mortality pattern up to 40 years, in both the healthy cardiovascular groups at supposedly high and low risk, and in some groups having cardiovascular disease at screening. Methods: At the screening, 16,203 (63% of those invited) men aged 40–49 years participated. Study groups were identified by means of questionnaires regarding diseases, blood pressure and measurements of total cholesterol, triglycerides and glucose. We identified six groups: very high cholesterol, very high blood pressure, very high glucose, non-smoking with non-elevated such risk factors, from a randomized diet and antismoking trial, and a randomized drug treatment in mild-to-moderate hypertension. Statistical analyses were by Cox regression analysis, with Kaplan-Meier graphs. Results: The supposedly low-risk group had a total mortality of one-third of other groups, such as: men with hypertension, diabetes or hypercholesterolemia, or those whom participated in the two trials. Between these latter groups, we found 2–5 years of difference in their median survival time, but their absolute risk stayed at rather high levels through all the years, with the median remaining a lifetime that was 3–8 years shorter than the men whom were free of known cardiovascular disease, diabetes or hypertension. Conclusions: The long-term preventive effects on total mortality seem large, if the levels of the classical risk factors of blood pressure, total cholesterol and glucose can be adequately controlled, concurrently with a non-smoking behavior. The study indicated that non-smoking and a low total cholesterol value were the most important contributors to extended survival.
- 9 January 2015
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 43 (2) , 117-122
Long-term survival in pre-specified groups at risk in the Oslo Study, 1972–1973
Aims: Using the Oslo Study of 1972–1973, we wished to compare the long-term mortality pattern up to 40 years, in both the healthy cardiovascular groups at supposedly high and low risk, and in some groups having cardiovascular disease at screening. Methods: At the screening, 16,203 (63% of those invited) men aged 40–49 years participated. Study groups were identified by means of questionnaires regarding diseases, blood pressure and measurements of total cholesterol, triglycerides and glucose. We identified six groups: very high cholesterol, very high blood pressure, very high glucose, non-smoking with non-elevated such risk factors, from a randomized diet and antismoking trial, and a randomized drug treatment in mild-to-moderate hypertension. Statistical analyses were by Cox regression analysis, with Kaplan-Meier graphs. Results: The supposedly low-risk group had a total mortality of one-third of other groups, such as: men with hypertension, diabetes or hypercholesterolemia, or those whom participated in the two trials. Between these latter groups, we found 2–5 years of difference in their median survival time, but their absolute risk stayed at rather high levels through all the years, with the median remaining a lifetime that was 3–8 years shorter than the men whom were free of known cardiovascular disease, diabetes or hypertension. Conclusions: The long-term preventive effects on total mortality seem large, if the levels of the classical risk factors of blood pressure, total cholesterol and glucose can be adequately controlled, concurrently with a non-smoking behavior. The study indicated that non-smoking and a low total cholesterol value were the most important contributors to extended survival.
- Open Access
- 1 October 2014
- Published by S. Karger AG in Obesity Facts
- Vol. 7 (5) , 311-321
Increased Predictive Ability of BMI but not Other Risk Factors with Time in Men: 39-Year Follow-Up of Total Mortality in the Oslo Study
Objective: Risk factor associations to mortality may change, in part due to removal of high-risk persons. We compared strengths of association and ability of risk factors to predict total mortality across short (Methods: Cardiovascular risk factors were measured in 1972-1973 in the Oslo Study among 14,846 men born in 1923-1932. Relationships of risk factors to mortality (to 2011) were analyzed using Cox regression models, and receiver operating characteristics (ROC) were estimated. Results: BMI was the only factor that increased strength of association with elapsed time (hazard ratio for ≥35 kg/m2 vs. 22.5-24.9 kg/m2: 1.25 (95% CI 0.73-2.17), 1.51 (95% CI 1.06-2.16) and 3.73 (95% CI 2.33-5.98) for Discussion: Risk factors differed in association strengths and ability to predict mortality over four decades. BMI strengthened its association with time, while cigarette smoking was strongest in all periods.
- 1 October 2014
- Published by S. Karger AG in Obesity Facts
- Vol. 7 (5) , 311-321
Open AccessIncreased Predictive Ability of BMI but not Other Risk Factors with Time in Men: 39-Year Follow-Up of Total Mortality in the Oslo Study
Objective: Risk factor associations to mortality may change, in part due to removal of high-risk persons. We compared strengths of association and ability of risk factors to predict total mortality across short (Methods: Cardiovascular risk factors were measured in 1972-1973 in the Oslo Study among 14,846 men born in 1923-1932. Relationships of risk factors to mortality (to 2011) were analyzed using Cox regression models, and receiver operating characteristics (ROC) were estimated. Results: BMI was the only factor that increased strength of association with elapsed time (hazard ratio for ≥35 kg/m2 vs. 22.5-24.9 kg/m2: 1.25 (95% CI 0.73-2.17), 1.51 (95% CI 1.06-2.16) and 3.73 (95% CI 2.33-5.98) for Discussion: Risk factors differed in association strengths and ability to predict mortality over four decades. BMI strengthened its association with time, while cigarette smoking was strongest in all periods.
- Open Access
- 30 September 2014
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 134 (18) , 1743-8
Fysisk aktivitet, røyking og dødelighet hos menn som deltok i Oslo-undersøkelsene i 1972 og 2000
Few Norwegian data are available on the importance of physical activity with regard to mortality. Our objective was to study mortality in light of leisure time physical activity and smoking. Men born in the period 1923-1932 were included in the Oslo Study in 1972-1973 and then investigated again in 2000. A total of 5738 men were included in the analyses. Physical activity was registered as self-reported number of hours at low and high intensity, as well by the Gothenburg question on the degree of leisure activity (sedentary, low, moderate, high). Cox regression analysis was used for statistical computation. After 12 years, men who reported a moderate amount of activity (approximately 30 minutes per day six times per week of low or high activity) in the year 2000 had a 40% lower mortality rate than the physically inactive (the reference group). A change in activity level in older age was independently associated with a risk of death. The Gothenburg question on amount of activity gave the same predictive information value as smoking. Our data indicate that there is a dose-response relationship between the degree of physical activity and early death. An increase in activity was just as strongly associated with reduced mortality as quitting smoking. Based on these data, physical activity should be recommended as a daily habit.
- 30 September 2014
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 134 (18) , 1743-8
Open AccessFysisk aktivitet, røyking og dødelighet hos menn som deltok i Oslo-undersøkelsene i 1972 og 2000
Few Norwegian data are available on the importance of physical activity with regard to mortality. Our objective was to study mortality in light of leisure time physical activity and smoking. Men born in the period 1923-1932 were included in the Oslo Study in 1972-1973 and then investigated again in 2000. A total of 5738 men were included in the analyses. Physical activity was registered as self-reported number of hours at low and high intensity, as well by the Gothenburg question on the degree of leisure activity (sedentary, low, moderate, high). Cox regression analysis was used for statistical computation. After 12 years, men who reported a moderate amount of activity (approximately 30 minutes per day six times per week of low or high activity) in the year 2000 had a 40% lower mortality rate than the physically inactive (the reference group). A change in activity level in older age was independently associated with a risk of death. The Gothenburg question on amount of activity gave the same predictive information value as smoking. Our data indicate that there is a dose-response relationship between the degree of physical activity and early death. An increase in activity was just as strongly associated with reduced mortality as quitting smoking. Based on these data, physical activity should be recommended as a daily habit.
- Open Access
- 1 February 2013
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 8 (2) , 241-247
Model Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients
Summary: Background and objectives: Risk factor analysis of long-term graft survival in kidney transplant recipients is usually based on Cox regression models of time to first occurrence of doubling of serum creatinine or graft loss (DSCGL). However, death is a competing cause of failure, and censoring patients who die could bias estimates. We therefore compared estimates of time to first event versus estimates that included death as a competing risk and recurrent events. Design, setting, participants, & measurements: A Cox regression analysis of 1997–2002 data from the Assessment of Lescol in Renal Transplant (ALERT) trial population identified an eight-factor risk model, by analyzing time to first occurrence of DSCGL. The same factors were re-analyzed, allowing for death as competing. The probability of survival free of DSCGL was estimated; and two recurrent models (marginal and conditional) were used for time to events. Results: Creatinine, systolic BP, and HLA-DR mismatches lost 33%–46% of their strength of association with DSCGL when death was included as a competing risk. Small changes were observed if recurrent events were analyzed in the marginal model. Conclusion: The relationship between serum creatinine and DSCGL was attenuated when death was considered as a competing risk; inclusion of recurrent events had little effect. These findings have important implications for analysis and trial design in populations at high mortality risk.
- 1 February 2013
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 8 (2) , 241-247
Open AccessModel Comparisons of Competing Risk and Recurrent Events for Graft Failure in Renal Transplant Recipients
Summary: Background and objectives: Risk factor analysis of long-term graft survival in kidney transplant recipients is usually based on Cox regression models of time to first occurrence of doubling of serum creatinine or graft loss (DSCGL). However, death is a competing cause of failure, and censoring patients who die could bias estimates. We therefore compared estimates of time to first event versus estimates that included death as a competing risk and recurrent events. Design, setting, participants, & measurements: A Cox regression analysis of 1997–2002 data from the Assessment of Lescol in Renal Transplant (ALERT) trial population identified an eight-factor risk model, by analyzing time to first occurrence of DSCGL. The same factors were re-analyzed, allowing for death as competing. The probability of survival free of DSCGL was estimated; and two recurrent models (marginal and conditional) were used for time to events. Results: Creatinine, systolic BP, and HLA-DR mismatches lost 33%–46% of their strength of association with DSCGL when death was included as a competing risk. Small changes were observed if recurrent events were analyzed in the marginal model. Conclusion: The relationship between serum creatinine and DSCGL was attenuated when death was considered as a competing risk; inclusion of recurrent events had little effect. These findings have important implications for analysis and trial design in populations at high mortality risk.
- 30 November 2011
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 20 (1) , 168-175
Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.
- 30 November 2011
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 20 (1) , 168-175
Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.